More women with congenital heart disease survive to childbearing ages, due to improvements in surgical practice and postoperative care. This review discusses pregnancy in women with a single ventricle, describing maternal obstetric and cardiovascular complications and the increased risks of prematurity and adverse neonatal outcomes. Recommendations are made based on current understanding, guidelines and published literature, with recognition that there is much knowledge yet to be gained.
GewilligMBrownSC. The Fontan circulation after 45 years: update in physiology. Heart2016; 102: 1081–1086.
2.
ClarkSLCottonDBLeeWet al.Central hemodynamic assessment of normal term pregnancy. Am J Obstet Gynecol1989; 161(6 Pt 1): 1439–1442.
3.
RobsonSCHunterSBoysRJet al.Serial study of factors influencing changes in cardiac output during human pregnancy. Am J Physiol1989; 256: H1060–H1065.
4.
Knight M, Nair M, Tuffnell D, et al. (eds.) on behalf of MBRRACE-UK. Saving lives, improving mothers’ care – surveillance of maternal deaths in the UK 2012–2014 and lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2009–14. Oxford: University of Oxford, National Perinatal Epidemiology Unit, 2016.
5.
Humphrey M. Maternal mortality trends in Australia. The Medical Journal of Australia 2016; 205(8): 344–346.
6.
GrewalJSiuSCRossHJet al.Pregnancy outcomes in women with dilated cardiomyopathy. J Am Coll Cardiol2009; 55: 45–52.
7.
TzemosNSilversidesCKColmanJMet al.Late cardiac outcomes after pregnancy in women with congenital aortic stenosis. Am Heart J2009; 157: 474–480.
8.
MoneSMSandersSPColanSD. Control mechanisms for physiological hypertrophy of pregnancy. Circulation1996; 94: 667–672.
9.
ZentnerDdu PlessisMBrenneckeSet al.Deterioration in cardiac systolic and diastolic function late in normal human pregnancy. Clin Sci (Lond)2009; 116: 599–606.
10.
SableCFosterEUzarkKet al.Best practices in managing transition to adulthood for adolescents with congenital heart disease: the transition process and medical and psychosocial issues: a Scientific Statement From the American Heart Association. Circulation2011; 123: 1454–1485.
11.
Regitz-ZagrosekVBlomstrom LundqvistCet al.ESC Guidelines on the management of cardiovascular diseases during pregnancy: the task force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J2011; 32: 3147–3197.
12.
SiuSCSermerMColmanJMet al.Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation2001; 104: 515–521.
13.
DrenthenWBoersmaEBalciAet al.Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J2010; 31: 2124–2132.
14.
BalciASollie-SzarynskaKMvan der BijlAGLet al.Prospective validation and assessment of cardiovascular and offspring risk models for pregnant women with congenital heart disease. Heart2014; 100: 1373–1381.
15.
LuiGKSilversidesCKKhairyPet al.Heart rate response during exercise and pregnancy outcome in women with congenital heart disease. Circulation2011; 123: 242–248.
16.
OhuchiHNegishiJNoritakeKet al.Prognostic value of exercise variables in 335 patients after the Fontan operation: a 23-year single-center experience of cardiopulmonary exercise testing. Congenit Heart Dis2015; 10: 105–116.
DrenthenWPieperPGRoos-HesselinkJWet al.Pregnancy and delivery in women after Fontan palliation. Heart2006; 92: 1290–1294.
19.
ZentnerDKotevskiAKingIet al.Fertility and pregnancy in the Fontan population. Int J Cardiol2016; 208: 97–101.
20.
WarnesCAWilliamsRGBashoreTMet al.ACC/AHA 2008 Guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease) Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol2008; 52: e143–e263.
21.
PohCLZanninoDWeintraubRGet al.Three decades later: the fate of the population of patients who underwent the atriopulmonary Fontan procedure. Int J Cardiol2017; 231: 99–104.
22.
GoutonMNizardJPatelMet al.Maternal and fetal outcomes of pregnancy with Fontan circulation: a multicentric observational study. Int J Cardiol2015; 187: 84–89.
23.
BoivinJBuntingLCollinsJAet al.International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care. Hum Reprod2007; 22: 1506–1512.
24.
AggarwalNChopraSSuriVet al.Pregnancy outcome in women with autoimmune hepatitis. Arch Gynecol Obstet2011; 284: 19–23.
25.
BradleyRJRosenMP. Subfertility and gastrointestinal disease: ‘unexplained’ is often undiagnosed. Obstet Gynecol Surv2004; 59: 108–117.
26.
ØstensenMBrucatoACarpHet al.Pregnancy and reproduction in autoimmune rheumatic diseases. Rheumatology2011; 50: 657–664.
27.
GuglielmiKE. Women and ESRD: modalities, survival, unique considerations. Adv Chronic Kidney Dis2013; 20: 411–418.
28.
FatiniCContiLTurillazziVet al.Unexplained infertility: association with inherited thrombophilia. Thromb Res2012; 129: e185–e188.
29.
BellverJSoaresSRAlvarezCet al.The role of thrombophilia and thyroid autoimmunity in unexplained infertility, implantation failure and recurrent spontaneous abortion. Hum Reprod2008; 23: 278–284.
30.
Roos-HesselinkJWJohnsonMR. Pregnancy and congenital heart disease, Switzerland: Springer International Publishing, 2017.
31.
GriebelCPHalvorsenJGolemonTBet al.Management of spontaneous abortion. Am Fam Phys2005; 72: 1243–1250.
32.
Tomkiewicz-PajakLHoffmanPTrojnarskaOet al.Abnormalities in blood coagulation, fibrinolysis, and platelet activation in adult patients after the Fontan procedure. J Thorac Cardiovasc Surg2014; 147: 1284–1290.
33.
de HaasSGhossein-DohaCvan KuijkSMet al.Physiological adaptation of maternal plasma volume during pregnancy: a systematic review and meta-analysis. Ultrasound Obstet Gynecol2017; 49: 177–187.
34.
Soma-PillayPCatherineN-PTolppanenHet al.Physiological changes in pregnancy. Cardiovasc J Africa2016; 27: 89–94.
35.
CarlinAAlfirevicZ. Physiological changes of pregnancy and monitoring. Best Pract Res Clin Obstet Gynaecol2008; 22: 801–823.
36.
BettGC. Hormones and sex differences: changes in cardiac electrophysiology with pregnancy. Clin Sci (Lond)2016; 130: 747–759.
37.
BrooksVLDampneyRALHeeschCM. Pregnancy and the endocrine regulation of the baroreceptor reflex. Am J Physiol2010; 299: R439–R451.
38.
FuQLevineBD. Autonomic circulatory control during pregnancy in humans. Semin Reprod Med2009; 27: 330–337.
39.
GowdaRMKhanIAMehtaNJet al.Cardiac arrhythmias in pregnancy: clinical and therapeutic considerations. Int J Cardiol2003; 88: 129–133.
40.
DennisATCastroJCarrCet al.Haemodynamics in women with untreated pre-eclampsia. Anaesthesia2012; 67: 1105–1118.
41.
d'UdekemYIyengarAJGalatiJCet al.Redefining expectations of long-term survival after the Fontan procedure: twenty-five years of follow-up from the entire population of Australia and New Zealand. Circulation2014; 130(11 Suppl 1): S32–S38.
42.
CarinsTAShiWYIyengarAJet al.Long-term outcomes after first-onset arrhythmia in Fontan physiology. J Thorac Cardiovasc Surg2016; 152: 1355–1363.e1.
43.
GrattanMMertensL. Mechanics of the functionally univentricular heart – how little do we understand and why does it matter?Can J Cardiol2016; 32: 1033.e11–e18.
44.
RosenthalDNFriedmanAHKleinmanCSet al.Thromboembolic complications after Fontan operations. Circulation1995; 92: 287–293.
BossersSSMKapustaLKuipersIMet al.Ventricular function and cardiac reserve in contemporary Fontan patients. Int J Cardiol2015; 196: 73–80.
47.
WhitehouseK. Common symptoms in pregnancy. InnovAiT2010; 3: 539–544.
48.
ZibMLimLWaltersW. Symptoms during normal pregnancy: a prospective controlled study. Aust N Z J Obstet Gynaecol1999; 39: 401–410.
49.
ShotanAOstrzegaEMehraAet al.Incidence of arrhythmias in normal pregnancy and relation to palpitations, dizziness, and syncope. Am J Cardiol1997; 79: 1061–1064.
50.
SilversidesCKBradleyTColmanJet al.Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: executive summary. Can J Cardiol2010; 26: 143–150.
51.
CanobbioMMWarnesCAAboulhosnJet al.Management of pregnancy in patients with complex congenital heart disease: a scientific statement for healthcare professionals from the American Heart Association. Circulation2017; 135: e50–e87.
52.
CauldwellMVon KlempererKUebingAet al.Why is post-partum haemorrhage more common in women with congenital heart disease?Int J Cardiol2016; 218: 285–290.
LinnemannBScholzURottHet al.Treatment of pregnancy-associated venous thromboembolism – position paper from the Working Group in Women's Health of the Society of Thrombosis and Haemostasis (GTH). VASA Zeitschrift fur Gefasskrankheiten2016; 45: 103–118.
55.
EngelfrietPBoersmaEOechslinEet al.The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5 year follow-up period – the Euro Heart Survey on adult congenital heart disease. Eur Heart J2005; 26: 2325–2333.
56.
WilsonTGIyengarAJWinlawDSet al.Use of ACE inhibitors in Fontan: rational or irrational?Int J Cardiol2016; 210: 95–99.
57.
CraganJDYoungBACorreaA. Renin-angiotensin system blocker fetopathy. J Pediatr2015; 167: 792–794.
58.
PucciMSarweenNKnoxEet al.Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in women of childbearing age: risks versus benefits. Expert Rev Clin Pharmacol2015; 8: 221–231.
59.
MageeLDuleyL. Oral beta-blockers for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev2003; 3: CD002863–CD002863.
60.
ErsbollASHedegaardMSondergaardLet al.Treatment with oral beta-blockers during pregnancy complicated by maternal heart disease increases the risk of fetal growth restriction. BJOG2014; 121: 618–626.
61.
AbalosEDuleyLSteynDWet al.Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev2007; 1: CD002252–CD002252.
62.
BatemanBTPatornoEDesaiRJet al.Late pregnancy β blocker exposure and risks of neonatal hypoglycemia and bradycardia. Pediatrics2016; 138: pii: e20160731–pii: e20160731.
63.
AriasFZamoraJ. Antihypertensive treatment and pregnancy outcome in patients with mild chronic hypertension. Obstet Gynecol1979; 53: 489–494.
64.
PieperPG. Use of medication for cardiovascular disease during pregnancy. Nat Rev Cardiol2015; 12: 718–729.
65.
PundiKNPundiKJohnsonJNet al.Contraception practices and pregnancy outcome in patients after Fontan operation. Congenit Heart Dis2016; 11: 63–70.
66.
CauldwellMVon KlempererKUebingAet al.A cohort study of women with a Fontan circulation undergoing preconception counselling. Heart2016; 102: 534–540.
67.
Le GloanLMercierL-ADoreAet al.Pregnancy in women with Fontan physiology. Expert Rev Cardiovasc Ther2011; 9: 1547–1556.
68.
CollinsRT2ndChangDSandlinAet al.National in-hospital outcomes of pregnancy in women with single ventricle congenital heart disease. Am J Cardiol2017; 119: 1106–1110.
69.
CanobbioMMCettaFSilversidesCet al.Pregnancy after Fontan operation: early and late outcomes. J Am Coll Cardiol2013; 61: E427–E427.
70.
ZentnerDWheelerMGriggL. Does pregnancy contribute to systemic right ventricular dysfunction in adults with an atrial switch operation?Heart Lung Circ2012; 21: 433–448.
71.
DrenthenWPieperPGRoos-HesselinkJWet al.Outcome of pregnancy in women with congenital heart disease: a literature review. J Am Coll Cardiol2007; 49: 2303–2311.
72.
KenyonSTaylorDTarnow-MordiW. Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial. Lancet2001; 357: 979–988.
73.
MedinaTMHillDA. Preterm premature rupture of membranes: diagnosis and management. Am Fam Phys2006; 73: 659–664.
74.
GelsonECurryRGatzoulisMAet al.Effect of maternal heart disease on fetal growth. Obstet Gynecol2011; 117: 886–891.
75.
PieperPGBalciAAarnoudseJGet al.Uteroplacental blood flow, cardiac function, and pregnancy outcome in women with congenital heart disease. Circulation2013; 128: 2478–2487.
HoffmanJIEKaplanS. The incidence of congenital heart disease. J Am Coll Cardiol2002; 39: 1890–1900.
78.
StevensGAFinucaneMMDe-RegilLMet al.Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995–2011: a systematic analysis of population-representative data. Lancet Global Health2013; 1: e16–e25.
79.
OechslinE. Hematological management of the cyanotic adult with congenital heart disease. Int J Cardiol2004; 97(Supplement 1): 109–115.
80.
UebingASteerPJYentisSMet al.Pregnancy and congenital heart disease. Br Med J2006; 7538: 401–401.
81.
MonteiroRSDobDPCauldwellMRet al.Anaesthetic management of parturients with univentricular congenital heart disease and the Fontan operation. Int J Obstet Anesth2016; 28: 83–91.
82.
DobDPYentisSM. Practical management of the parturient with congenital heart disease. Int J Obstet Anesth2006; 15: 137–144.
83.
LagrewDCBushMCMcKeownAMet al.Emergent (crash) cesarean delivery: indications and outcomes. Am J Obstet Gynecol2006; 194: 1638–1643.
84.
SchillingCDalzielKNunnRet al.The Fontan epidemic: population projections from the Australia and New Zealand Fontan Registry. Int J Cardiol2016; 219: 14–19.
